Navigation Links
Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
Date:8/31/2007

EBAC-Accredited Workshop Set for Sept. 3

UPPSALA, Sweden and WILMINGTON, Mass., Aug. 31 /PRNewswire/ -- Nico Pijls, M.D., Ph.D., and Bernard de Bruyne, M.D., Ph.D., will present the benefits of measuring coronary pressure, or Fractional Flow Reserve (FFR), in improving the outcomes of multivessel PCI in a workshop at the European Society of Cardiology (ESC) Congress 2007 in Vienna. The EBAC-accredited workshop, which is sponsored by Radi Medical Systems, will take place at 12:45 p.m. CEST on Monday, Sept. 3, in the Copenhagen Room in Zone 1 of the Messe Wien Conference Center.

Dr. Pijls, of the department of cardiology at Catharina Hospital in Eindhoven, the Netherlands, will cover "Assessment Of Ischaemia In The Cathlab: The Best And Easiest Way To Go." Dr. de Bruyne, with the Cardiovascular Center Aalst in Aalst, Belgium, will explore the "Diagnosis And Treatment Of Multivessel Disease: All In One." Both physicians were investigators in the DEFER study, which evaluated the appropriateness of stenting a coronary stenosis (abnormal narrowing) that appears to be angiographically significant but is not restricting blood flow enough to cause symptoms. Five-year results were published in the May 29 issue of the Journal of the American College of Cardiology.

About FFR

FFR expresses maximum achievable blood flow in a coronary artery with abnormal stenosis as a fraction of normal maximum blood flow in the absence of a stenosis. It is calculated using an interventional guidewire with a specially designed sensor built into it. Using the well established value of 0.75, FFR is 100% specific in identifying which lesions are actually causing flow restriction and can be treated. FFR also documents the exact percentage of the reduction in flow associated with each lesion.

About Radi Medical Systems AB

Radi Medical Systems AB (Radi) develops, manufactures and sells medical devices designed to improve patient care. The compan
'/>"/>

SOURCE Radi Medical Systems AB
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. VC trends, company progress discussed at Mason Wells portfolio meeting
2. Rayovacs IT team discusses network security, Sarbanes-Oxley and ROI myths
3. State CIO discusses IT and government
4. Industry Veterans discuss the "next big thing"
5. Biotech Pioneer Discusses Breakthrough in Osteoporosis Treatment
6. Wisconsin Leaders Discuss Economic Development
7. Siemens health services president calls IT benefits unassailable
8. Miszewski touts benefits of IT integration
9. State criticized over BadgerNet 2 execution; some doubt benefits
10. U.S. manufacturing benefits if utilities can assist them with energy efficiency efforts
11. Sensenbrenner and USPTO Director highlight benefits of technology transfer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ink of it as origami very high-tech origami. , R...loped a technique for fabricating three-dimensiona... films by coupling photolithography and a self-fol...The films, only a few microns thick, offer mechani...pieces of the same material. , "This is a complet...
(Date:11/23/2009)...PRNewswire-FirstCall/--NeogenCorporation(Nasdaq: N...lectedtoNeogen,sBoardofDirectorsatthecompany,srece...ethan40yearsofexperienceinthefood,agriculture,andt...orofagriculturaleconomicsatVirginiaTechUniversity....chiefagriculturenegotiatorwiththerankofambassador....
(Date:11/23/2009)...v.23/PRNewswire/--PearlTherapeuticsInc.,abiopharma...treatmentofchronicrespiratorydiseases,todayannounc...irectors.Mr.Rosenhas25yearsofexperienceinthepharma...esatGileadSciencesandALZACorporation.Hisappointmen... ,, "Howiebringsawealthofproductdevelopment,com...
(Date:11/20/2009)... Dendreon Corporation (Na...nd Drug Administration (FDA) provided written ackn...icense Application (BLA) for PROVENGE® (sipul...gned a Prescription Drug User Fee Act (PDUFA) date...Dendreon,s amended BLA. Dendreon is seeking licen...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2Richard T. Crowder Joins Neogen's Board of Directors 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3
...yne, Inc.,(Nasdaq: RDYN ) announced today that it...2008 at 4:45 P.M. ET to report first quarter 2008,... Replidyne will host its,annual shareholder meetin...n Louisville, CO., Earnings conference call in...resident and CEO, and other members of Replidyne,s...
...Points from the First Quarter of 2007 to ...to Launch Newest Generation of Laser Lipolysis ...Mass., April 29 Cynosure, Inc.,(Nasdaq: CYNO ), ...ray of,light-based aesthetic treatment systems, to... the quarter ended March 31, 2008., First-Quarter...
...merica,Inc. (OTC Bulletin Board: CBAI), the umbili...tp://www.cordblood-america.com ) focused on,bring...ilies nationwide and,internationally, today report...erview with Francis Gaskins, said 2007 acquisition...d a 600 percent increase in gross profits., "We w...
Other Biology Technology:Replidyne to Report First Quarter 2008 Earnings 2Replidyne to Report First Quarter 2008 Earnings 3Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 2Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 3Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 4Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 5Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 6Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 7Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 8Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 9Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 10Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 11Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined 2
(Date:11/23/2009)...INGHAM, Ala. A new study by University of Alabama...ass index (BMI) and co-existing medical conditions...val observed among African-Americans compared to C... published online Nov. 23 in Cancer , a journal o...icates that although BMI and co-morbidity are inde...
(Date:11/23/2009)...S, Ore. A string of recent discoveries about the ...interest in this multi-purpose nutrient, increased...eficient in it, spurred research and even led to a... On issues ranging from the health of your immune ...nerability to influenza, vitamin D is now seen as ...
(Date:11/23/2009)...approach to classify the gender of six-week-old tu...m being killed shortly after birth, according to D...echnology in Germany and his team. Their use of in...ng birds shows that it is a fast and accurate meth...ndustry to identify and select female eggs for bre...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Rescuing male turkey chicks 2YM BIOSCIENCES SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG 12817 1YM BIOSCIENCES SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG 12817 2YM BIOSCIENCES SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG 12817 3YM BIOSCIENCES SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG 12817 4Prometheus Launches MyCeliacID 28TM 29 the First Do it Yourself Saliva Based Genetic Test Dedicated to Celiac Disease 50248 1Prometheus Launches MyCeliacID 28TM 29 the First Do it Yourself Saliva Based Genetic Test Dedicated to Celiac Disease 50248 2Prometheus Launches MyCeliacID 28TM 29 the First Do it Yourself Saliva Based Genetic Test Dedicated to Celiac Disease 50248 3Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market 12814 1Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market 12814 2Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market 12814 3Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market 12814 4
...ch Professor Benjamin Cravatt, Ph.D., is being pub...Biological Chemistry. , The new study describes a ...d-for the biosynthesis of neurotransmitter lipids,...dogenous cannabinoid ("endocannabinoid") anandamid...(Abh4) in areas such as the central nervous system...
...righteningly large if only there was a greater con...udes. The study adds support to the theory that so...oic period because they had a much richer oxygen s...er. , The study, "No giants today: tracheal oxygen...presented Oct. 10 and 11 at Comparative Physiology...
...earch-and-destroy quest for weeds, will soon be mo... fields at the University of Illinois. What,s more...ile significantly reducing herbicide use. , The ro...ll cameras mounted on a frame on top of the machin...human, said Lei Tian, agricultural engineer at the...
Other Biology News:Nanotechnology propels advances in regenerative medicine research 2Giant insects might reign if only there was more oxygen in the air 2Giant insects might reign if only there was more oxygen in the air 3New system could drastically reduce herbicide use 2New system could drastically reduce herbicide use 3
...ion Kit provides a powerful yet simple technology ... nuceleic acids. The kit provides the heterobifunc...r quantifying conjugation efficiencies. It enables...uorophores, biotin and other tags with a variety o...
...ometer provides the sensitivity and versatility yo...ced digital photon counting with selected photomul...h of spectral demands. Equipped with up to 2 reage...ter gene assays as well as other luminescence appl...
BD Falcon TufRol Cell Culture Flask, 25 cm2 from BD Biosciences - Discovery Labware
BD Falcon Cell Culture Flask, 25 cm2 from BD Biosciences - Discovery Labware
Biology Products: